Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders

 
 

Vascular Biogenics Ltd. (VBLT) Add to portfolio


Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-22Dec-31-21Dec-31-20Dec-31-19Dec-31-18Dec-31-16Dec-31-15Dec-31-14
Revenues0.70.80.90.60.632.629.729.6
            Revenue growth-14.3%-16.7%64.1%-3.9% 9.4%0.6%-7.4%
Cost of goods sold0.10.40.40.20.30.00.00.0
Gross profit0.60.40.50.30.332.629.729.6
            Gross margin84.2%52.5%57.3%60.5%56.4%100.0%100.0%100.0%
Sales and marketing    0.4   
Research and development22.923.221.117.415.212.411.211.0
General and administrative11.87.75.45.76.03.83.73.8
EBIT-32.9-30.0-24.5-20.121.216.314.914.8
            EBIT margin-4992.9%-3905.7%-2655.4%-3573.3%3631.6%50.0%50.0%50.0%
Pre-tax income32.329.924.219.420.50.00.00.0
Income taxes0.00.00.00.00.00.00.00.0
            Tax rate0.0%0.0%0.0%0.0%0.0%   
Net income32.329.924.219.420.50.00.00.0
            Net margin4909.4%3895.8%2627.4%3451.2%3503.6%0.0%0.0%0.0%
 
Diluted EPS$0.42$0.45$0.55$0.54$0.62   
Shares outstanding (diluted)77.666.343.735.933.0   
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy